Cedars-Sinai Cancer Advances Leadership Roles | Newswise
Cedars-Sinai Cancer Advances Leadership Roles | Newswise Newswise
Cedars-Sinai Cancer Advances Leadership Roles | Newswise Newswise
PharmaMar Joins OncoDaily Grand Rounds at ESMO 2026: Sarcoma Edition as Foundational Partner Oncodaily
Tip Sheet: A new assay for ovarian and breast cancers, RSV treatment effectiveness — and the impact of genetic testing for hereditary cancers | Newswise Newswise
Российские ученые нашли фактор, влияющий на успех лечения рака кожи ОНТ
Прорыв в лечении рака — учёные нашли способ продлить работу имунных клеток Поиск - новости науки и техники
Cristiane Bergerot: Exploring Cancer-Related Discrimination Oncodaily
Cancer Cases Rising Significantly Among Under 50s in England European Medical Journal
Инновация в клиниках США: как безболезненное удаление рака привело к летальной статистике Правда.Ру
Key Driver of Aggressive Prostate Cancer Identified, Suggesting New Way to Reverse Drug Resistance | Newswise Newswise
Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine whether prostate tumors remain sensitive to treatment or evolve into a more aggressive, drug-resistant form of the disease.
SPIN Study Explores Pelvic Floor Care for Women With Bladder Cancer University of Miami
Jeffrey Lee: Celebrating 20 Years of Progress in Inflammatory Breast Cancer Research and Care Oncodaily
Renal cell carcinoma (RCC) is the most common form of kidney cancer, accounting for about 90% of kidney cancers. It develops when abnormal cells in the kidney's small tubules begin to grow uncontrollably. RCC has several subtypes that differ in their origin, molecular characteristics and genetic makeup.